Emmanuelle LERAY Directrice de recherche Inserm

Identifiants chercheurs

IdHAL :

emmanuelle-leray

ORCID :

0000-0001-8424-4499

IdRef :

099858185

VIAF :

208213321

ISNI :

000000035866868X

Publications

Communication dans un congrès (56)

SEP et dépistage des cancers : comment éviter la double peine ? Chloé Pierret,Bouvier Romane,Sandrine Kerbrat,Emmanuelle Leray Journées de Neurologie de Langue Française 2026, Association JNLF, Apr 2026, Marseille, France. pp.S132-S133 / P253, ⟨10.1016/j.neurol.2026.02.061⟩ Communication dans un congrès hal-05577940v1
Femmes et hommes atteints de sclérose en plaques : le recours aux soins symptomatiques est-il équitable ? Marie Mainguy,Emmanuelle Leray,Cécile Donzé Journées de Neurologie de Langue Française 2026, Association JNLF, Apr 2026, Marseille, France. pp.S131 / P250, ⟨10.1016/j.neurol.2026.02.058⟩ Communication dans un congrès hal-05577905v1
Prise en charge des troubles urinaires dans la sclérose en plaques : analyse nationale en vie réelle à partir des données du SNDS Cécile Donze,Emmanuelle Leray,Emmanuel Chartier-Kastler,Souad Meillassoux,Camille Roussillonet al. Journées de Neurologie de Langue Française 2026, Association JNLF, Apr 2026, Marseille, France. pp.S34 / P061, ⟨10.1016/j.neurol.2026.01.132⟩ Communication dans un congrès hal-05577891v1
Association entre comorbidités et utilisation des traitements de fond chez les patients ayant une sclérose en plaques rémittente-récurrente au sein de la cohorte OFSEP-HD Jean-Paul Niguet,Arnaud Kwiatkowski,Chloé Pierret,Emmanuelle Leray,Nomadmus Study Group And The Observatoire Français de La Sclérose En Plaques (ofsep) Journées de Neurologie de Langue Française 2026, Association JNLF, Apr 2026, Marseille, France. pp.S129-S130 / P248, ⟨10.1016/j.neurol.2026.02.056⟩ Communication dans un congrès hal-05577923v1
Urinary Dysfunction Management in Multiple Sclerosis: A Nationwide Real-Life Analysis From the French SNDS Database Cécile Donze,Emmanuelle Leray,Alexandre Vimont,Manon Santrisse,Souad Meillassouxet al. ISPOR Europe 2025, The Professional Society for Health Economics and Outcomes Research, Nov 2026, Glasgow, United Kingdom. pp.S319 / EPH275, ⟨10.1016/j.jval.2025.09.1404⟩ Communication dans un congrès hal-05446264v1
Multiple sclerosis-related healthcare and disease-modifying drug use before and after a cancer diagnosis a multi-national cohort study Chloe Pierret,H. Ng,Sandra Vukusic,Christine Lebrun-Frénay,Géraldine Androdiaset al. 19ème Conférence francophone d’Épidémiologie Clinique et 32èmes Journées des Statisticiens des Centres de Lutte Contre le Cancer, Comité scientifique et le comité d’organisation EPICLIN2025 / JSCLCC32, May 2025, Bordeaux, France. pp.203058 / P28, ⟨10.1016/j.jeph.2025.203058⟩ Communication dans un congrès hal-05071238v1
Fighting health crisis with solidarity: managing the surge of severe patients at the start of the COVID pandemic Olivier Grimaud,Anne Girault,Paula Cucharero Atienza,Emmanuelle Leray,Sahar Bayatet al. European Health Management Conference 2025 (EHMA), European Health Management Association (EHMA), Jun 2025, Rennes, France. pp.101 / ID 146 Communication dans un congrès hal-05574623v1
Impact of cancer on multiple sclerosis-related healthcare and disease-modifying drug use: a multi-national cohort study Chloe Pierret,Myriam Maumy,Huah Shin Ng,Sandra Vukusic,Christine Lebrun-Frénayet al. European Health Management Conference 2025 (EHMA), European Health Management Association (EHMA), Jun 2025, Rennes, France. pp.105 / ID 151 Communication dans un congrès hal-05574683v1
Developing patient-centred care (PCC) in Multiple Sclerosis: French preliminary results from a European project Anne-Lise Le Hesran,Christelle Routelous,Anne Girault,Emmanuelle Leray European Health Management Conference 2025 (EHMA), European Health Management Association (EHMA), Jun 2025, Rennes, France Communication dans un congrès hal-05574487v1
Le risque de cancer dans la sclérose en plaques : une étude de cohorte nationale à partir du Système national des données de santé (SNDS), 2012-2021 Chloe Pierret,A. Mulliez,C. Le Bihan-Benjamin,X. Moisset,P-J. Bousquetet al. Congrès ÉMOIS 2024, Association COPSICOM, Apr 2024, Lille, France. pp.202235, ⟨10.1016/j.jeph.2024.202235⟩ Communication dans un congrès hal-04543814v1
Le risque du cancer dans la SEP : une étude de cohorte nationale (2012–2021) C. Pierret,Aurélien Mulliez,Christine Le Bihan-Benjamin,Adil Maarouf,Philippe-Jean Bousquetet al. Journées Neurologies de Langue Française 2024, Association JNLF, Apr 2024, Paris, France. pp.S39-S40, ⟨10.1016/j.neurol.2024.02.074⟩ Communication dans un congrès hal-04529585v1
Inégalités socio-territoriales et mortalité en excès de patients atteints d'une sclérose en plaques en France : une étude rétrospective-observationnelle S. Wilson,Emmanuelle Leray,L. Guittet,G. Defer,O. Dejardin Xème Congrès International Francophone Épidémiologie et Santé publique « Les nouvelles transitions épidémiologiques », Association des Épidémiologistes de Langue Française (Adelf); Association pour le développement de l’EPIdémiologie de TERrain (Epiter), Jul 2024, Limoges, France. pp.202611 / 12-2, ⟨10.1016/j.jeph.2024.202611⟩ Communication dans un congrès hal-04782016v1
Risque de poussée après vaccination contre le COVID-19 chez les patients atteints de sclérose en plaques en France utilisant un design « self-controlled case series » A. Mulliez,X. Moisset,C. Chenaf,F. Taithe,S. Vukusicet al. EPICLIN 2024, 18ème Conférence francophone d’Épidémiologie Clinique, 31èmes journées des statisticiens des centres de lutte contre le cancer, Réseau national de recherche en épidémiologie clinique et en santé publique (RECaP); Association des Epidémiologistes De Langue Française (ADELF); Réseau national des statisticiens des CLCC, May 2024, Dijon, France. pp.202466 / P26, ⟨10.1016/j.jeph.2024.202466⟩ Communication dans un congrès hal-04578329v1
Enjeux, développements et perspectives de la prise en charge de la SEP Emmanuelle Leray Congrès "Pharmaco-épidémiologie & aide à la décision publique", EPI-PHARE, Nov 2024, En ligne, France Communication dans un congrès hal-05000510v1
Dépistage du cancer du sein chez les personnes atteintes de la sclérose en plaques C. Pierret,L Philippe,Emmanuelle Leray Congrès ÉMOIS 2024, Apr 2024, Lille, France. pp.202364 / P67, ⟨10.1016/j.jeph.2024.202364⟩ Communication dans un congrès hal-04694861v1
Age-based comparison of patients with heart failure treated with sacubitril-valsartan in France: a real-world evaluation O. Hanon,A. Cohen,P. Jourdain,E. Leray,G de Pouvourvilleet al. ESC Congress, Aug 2024, London, United Kingdom. ⟨10.1093/eurheartj/ehae666.926⟩ Communication dans un congrès hal-04849248v1
Influence des inégalités socio-territoriales sur la mortalité en excès de patients atteints de SEP en France : une étude rétrospective observationnelle Sarah Wilson,Emmanuelle Leray,Floriane Calocer,Lydia Guittet,Olivier Dejardinet al. Journées Neurologies de Langue Française 2024, Association JNLF, Apr 2024, Paris, France. pp.S134-S135, ⟨10.1016/j.neurol.2024.02.265⟩ Communication dans un congrès hal-04530561v1
Real-world evaluation of mortality in patients with heart failure treated with Sacubitril-Valsartan in France D. Logeart,A. Cohen,O. Hanon,P. Jourdain,G. de Pouvourvilleet al. JESFC 2024, Jan 2024, Paris, France. pp.S45-S45, ⟨10.1016/j.acvd.2023.10.080⟩ Communication dans un congrès hal-04414780v1
Dépistage du cancer du sein chez les personnes atteintes d’une SEP C. Pierret,Lou Philipe,Emmanuelle Leray Journées Neurologies de Langue Française 2024, Apr 2024, Paris, France. pp.S149, ⟨10.1016/j.neurol.2024.02.293⟩ Communication dans un congrès hal-04529513v1
Risk of relapse after COVID-19 vaccine among patients with multiple sclerosis in France: a self-controlled case series Emmanuelle Leray,Xavier Moisset,Chenaf Chouki,Frederic Taithe,Sandra Vukusicet al. 9th Joint ECTRIMS-ACTRIMS meeting, ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis); ACTRIMS (Americas Committee for Treatment and Research in Multiple Sclerosis), Oct 2023, Milan, Italy. pp.137-393 / P046/1364, ⟨10.1177/13524585231196192⟩ Communication dans un congrès hal-04387686v1
Impact of education level on multiple sclerosis disability progression in France Mathilde Lefort,O. Dejardin,F. Calocer,G. Defer,Emmanuelle Leray 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct 2022, Amsterdam, Netherlands. pp.113-114 / O154, ⟨10.1177/13524585221123685⟩ Communication dans un congrès hal-03925167v1
High and low efficacy therapy in secondary progressive multiple sclerosis I. Roos,Emmanuelle Leray,K. Buzzard,O. Skibina,J. Lechner-Scottet al. 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis), Oct 2022, Amsterdam, Netherlands. pp.6-6, ⟨10.1212/WNL.96.15_supplement.266⟩ Communication dans un congrès hal-04056219v1
Pregnancy in women with neuromyelitis optica spectrum disorders: recommendations from the French multiple sclerosis society S. Vukusic,R. Marignier,J. Ciron,B Bourre,M. Cohenet al. 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, European Comm Treatment & Res Multiple Sclerosis, Oct 2022, Amsterdam, Netherlands. pp.40-42 - ref O052 Communication dans un congrès hal-04989671v1
TRANSCOV, a multidisciplinary project to evaluate long distance COVID patients transfers Olivier Grimaud,Anne Girault,Laetitia Laude,Nicolas Sirven,P. Cucharero Atienzaet al. 14th European Public Health Conference Public health futures in a changing world, EPH Conference Foundation, Nov 2021, Virtual Event, France. pp.316-316, ⟨10.1093/eurpub/ckab164.837⟩ Communication dans un congrès hal-03553982v1
Pour l’instant, ça va ! : la déprise professionnelle des personnes avec une sclérose en plaques Pierre Brasseur,Espagnacq Maude,Pichetti Sylvain,Alice Guilleux,Regeart Camilleet al. Colloque ALTER European Society for Disability Research, Apr 2021, Rennes, France Communication dans un congrès halshs-03750919v1
Apports de la prise en charge homéopathique en soins de support dans le cancer du sein : Impact sur la consommation des traitements palliant les effets indésirables liés à la prise en charge du cancer du sein - Étude d’après les données du Système National des Données de Santé (SNDS) Jacques Medioni,Daniel Scimeca,Ycenia Lopez Marquez,Emmanuelle Leray,Marie Dalichamptet al. 13è Colloque Données de Santé en Vie Réelle, Le groupe de travail Real World Data (RWD) de l’AFCROs (Association Française des Centres de Ressources et d’Orientation pour les Soins de Support), Jun 2021, Paris, France. pp.S88-S89, ⟨10.1016/j.respe.2021.05.011⟩ Communication dans un congrès hal-03820863v1
Disease reactivation after cessation of disease-modifying therapy in relapsing-remitting multiple sclerosis I. Roos,C. B. Malpas,E. Leray,K. Buzzard,O. Skibinaet al. 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis), Oct 2021, Distanciel, Austria. pp.A4.1-A4 / 008, ⟨10.1136/bmjno-2021-anzan.8⟩ Communication dans un congrès hal-04056223v1
Improving the decision to switch from first to second-line therapy in MS: a dynamic scoring system C. Sabathe,Romain Casey,S. Vukusic,Emmanuelle Leray,G. Matheyet al. 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2021), European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct 2021, Virtuel - Online, France. pp.22-24, Oral Presentation 035, ⟨10.1177/13524585211044647⟩ Communication dans un congrès hal-03464227v1
Determinants of Therapeutic Lag in Multiple Sclerosis Izanne Roos,Emmanuelle Leray,Federico Frascoli,Romain Casey,Dana Horakovaet al. 62e Congrès annuel de l’American Academy of Neurology (AAN), American Academy of Neurology (AAN), Apr 2020, Toronto, Canada. ⟨10.1212/WNL.94.15_supplement.2059⟩ Communication dans un congrès hal-02929410v1
Understanding heterogeneity in comparative effectiveness studies of natalizumab and fingolimod in multiple sclerosis: effect of analytical methodology Mathilde Lefort,S. Shannin,Jørgen Vitting Andersen,S. Vukusic,N. J. Koch-Henriksenet al. 6th Congress of the European Academy of Neurology, European Academy of Neurology, May 2020, On line, United Kingdom. pp.342-342 Communication dans un congrès hal-02887182v1
Pregnancy outcomes in a French cohort of patients with Multiple Sclerosis: the MUSTANG project Hélène Tillaut,A.S. Kerbrat,A. Degremont,Elisabeth Polard,Emmanuelle Leray 6th Congress of the European Academy of Neurology, Virtual 2020, European Academy of Neurology, May 2020, ONLINE (Virtual), France. pp.476-476 Communication dans un congrès hal-02887183v1
L'invalidité pour les salariés qui ont une sclérose en plaques Pierre Brasseur,Maude Espagnacq,Sylvain Pichetti,Camille Regaert,Alice Guilleuxet al. Journées des économistes de la santé, Bruxelles, Dec 2020, Bruxelles, Belgique Communication dans un congrès halshs-03750922v1
Identification of Therapeutic Lag in Multiple Sclerosis (1787) Izanne Roos,Emmanuelle Leray,Federico Frascoli,Romain Casey,Dana Horakovaet al. 62ème congrès annuel de l'American Academy of Neurology (AAN), American Academy of Neurology (AAN), Apr 2020, Toronto, Canada. pp.1787, ⟨10.1212/WNL.94.15_supplement.1787⟩ Communication dans un congrès hal-02929403v1
Geographical variations in access to expert centers for multiple sclerosis in France Emmanuelle Leray,F. Mamadou,A. Guilleux,Jonathan Roux,Olivier Grimaud 12th European Public Health Conference, Nov 2019, Marseille, France. pp.80-80, ⟨10.1093/eurpub/ckz185.205⟩ Communication dans un congrès hal-02470788v1
Excess mortality in patients with relapsing-onset multiple sclerosis depends on age rather than disease duration: new insights from an innovative flexible model applied on French OFSEP data ('Observatoire Francais de la Sclerose en Plaques') F. Rollot,M. Fauvernier,Z. Uhry,S. Vukusic,N. Bossardet al. 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis), Sep 2019, Stockhlom, Sweden. pp.103-104 / 274, ⟨10.1177/1352458519868070⟩ Communication dans un congrès hal-02363491v1
Long-term effect of interferon and Glatiramer acetate in real-world settings use on multiple sclerosis disability progression: Input of time-dependent propensity score Mathilde Lefort,Yohann Foucher,Rémi Lenain,Sandra Vukusic,Gilles Edanet al. 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, International Society for Pharmacoepidemiology (ISPE), Aug 2019, Pennsylvania, United States. pp.217-218 / 442, ⟨10.1002/pds.4864⟩ Communication dans un congrès hal-02302564v1
Effet de l’initiation précoce d’un traitement de fond sur la progression du handicap en sclérose en plaques rémittente : une étude observationnelle des données de l’OFSEP Mathilde Lefort,Vukusic Sandra,Romain Casey,Gilles Edan,Emmanuelle Leray 24èmes Journées de Neurologie de Langue Française, Association JNLF & Société Française de Neurologie (SFN), Apr 2019, Lille, France. pp.S87, ⟨10.1016/j.neurol.2019.01.243⟩ Communication dans un congrès istex hal-02921500v1
Évaluation des effets cumulés de traitement de fonds sur le risque de handicap chez les patients récurrents-rémittents Fabien Rollot,Romain Casey,Emmanuelle Leray,Marc Debouverie,Gilles Edanet al. 24èmes Journées de Neurologie de Langue Française, Association JNLF & Société Française de Neurologie (SFN), Apr 2019, Lille, France. pp.S77, ⟨10.1016/j.neurol.2019.01.219⟩ Communication dans un congrès istex hal-02921630v1
Étude des parcours de soins des patients ayant une sclérose en plaques en France sur la période 2007–2013 : une analyse des bases médico-administratives utilisant la méthode « Multichannel Sequence Analysis » Jonathan Roux,Olivier Grimaud,Emmanuelle Leray Colloque Adelf-Emois, COPSICOM et ADELF, Mar 2018, Montepellier, France. pp.S25, ⟨10.1016/j.respe.2018.01.053⟩ Communication dans un congrès hal-01740314v1
Comorbidités mentales et sclérose en plaques : étude française à partir des données de l’Assurance maladie A. Guilleux,Jonathan Roux,Emmanuelle Leray Colloque Adelf-Emois, COPSICOM et ADELF, Mar 2018, Montpellier, France. pp.S44, ⟨10.1016/j.respe.2018.01.098⟩ Communication dans un congrès hal-01740308v1
Propensity score methods The study of the effect of beta-interferon and glatiramer acetate on multiple sclerosis disability Mathilde Lefort,Gilles Edan,Emmanuelle Leray 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), International Society for Pharmacoepidemiology, Aug 2018, Prague, Czech Republic. pp.3-521 / 413, ⟨10.1002/pds.4629⟩ Communication dans un congrès hal-01879623v1
Quelle utilisation des traitements de fond chez des patients ayant une sclérose en plaques rémittente en France sur la période 1990–2017 ? Étude des données de l’Observatoire français de la SEP Emmanuelle Leray,Jonathan Roux,F. Rollot,Romain Casey,J. de Sezeet al. 10e Colloque "Données de santé en vie réelle", Ipsos Health, Jun 2018, Paris, France. pp.S227 / PC20, ⟨10.1016/j.respe.2018.04.033⟩ Communication dans un congrès hal-02921604v1
Relapses in patients with secondary progressive MS a matter of disease duration or age? K. Ahrweiller,Chloé Rousseau,Emmanuelle Leray,Emmanuelle Le Page,Emma Bajeuxet al. MSPARIS2017, 7th joint ECTRIMS - ACTRIMS meeting, Oct 2017, Paris, France. pp.60-60 / 198, ⟨10.1177/1352458517731283⟩ Communication dans un congrès hal-01715985v1
Consommations de soins des patients ayant une sclérose en plaques traités par fingolimod à partir d’un échantillon au 1/97e des données de l’assurance maladie en France Emmanuelle Leray,J. Roux,Olivier Grimaud Journées de Neurologie de langue française 2016, Association JNLF, Apr 2016, Nantes, France. pp.A94 - A95 / W34, ⟨10.1016/j.neurol.2016.01.228⟩ Communication dans un congrès hal-01740321v1
La survenue de poussées de sclérose en plaques influencée par le niveau de particules fines PM10 dans l’air Emmanuelle Leray,Estelle Le Pabic,J. Roux,Jean-Claude Ongagna,Denis Bardet al. Journées de Neurologie de langue française 2016, Association JNLF , Apr 2016, Nantes, France. pp.A24 / G01, ⟨10.1016/j.neurol.2016.01.050⟩ Communication dans un congrès hal-01740319v1
Peut-on mesurer le niveau de handicap moteur lié à la sclérose en plaques à partir des bases de l’Assurance maladie ? J. Roux,Olivier Grimaud,Emmanuelle Leray VIIe Congrès International d’Épidémiologie "Épidémiologie et santé publique", Epiter et Adelf, Sep 2016, Rennes, France. pp.S199 / D2-4, ⟨10.1016/j.respe.2016.06.076⟩ Communication dans un congrès hal-01740317v1
Utilisation des bases médico-administratives pour l’étude des parcours de soins des patients atteints de sclérose en plaques en France de 2007 à 2013 J. Roux,Nolwenn Le Meur,Olivier Grimaud,Emmanuelle Leray Vème congrès national conjoint Adelf-Emois « Système d’information hospitalier et Epidémiologie », Adelf-Emois, Mar 2016, Dijon, France. pp.S18 - S19 / G2, ⟨10.1016/j.respe.2016.01.061⟩ Communication dans un congrès hal-01740327v1
PEPS: a platform for supporting studies in pharmaco-epidemiology using medico-administrative databases Frédéric Balusson,Marie-Anne Botrel,Olivier Dameron,Yann Dauxais,Erwan Drezenet al. International Congress on e-Health Research, Oct 2016, Paris, France Communication dans un congrès hal-01380939v1
Use of administrative database to describe physician services utilization and care patterns in multiple sclerosis in France Emmanuelle Leray,J. Roux,Nolwenn Le Meur Abstracts from the World Congress of Neurology (WCN 2015), Oct 2015, Santiago, Chile. pp.e310--e311, ⟨10.1016/j.jns.2015.08.1092⟩ Communication dans un congrès hal-01228174v1
Does air pollution influence risk of relapse in multiple sclerosis? Emmanuelle Leray,E. Le Pabic,Christophe Fermanian,J.-C. Ongagna,Denis Bardet al. 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct 2015, Barcelona (ES), Spain Communication dans un congrès hal-04539462v1
Pollution atmosphérique et déclenchement de poussées de sclérose en plaques Emmanuelle Leray,Denis Bard,J.-C. Ongagna,J. de Seze Journées de Neurologie de langue française 2014, Association JNLF, Apr 2014, Strasbourg, France. pp.A235-A236 / CO-160, ⟨10.1016/j.neurol.2014.01.537⟩ Communication dans un congrès hal-04026596v1
Mental Health Disparities between Roma and Non-Roma Children in Romania E. Lee,Christophe Fermanian,O. Pez,Emmanuelle Leray,E. Yoonet al. XIV. Congress of the International Federation of Psychiatric Epidemiology (IFPE). "The uses of psychiatric epidemiology in improving population mental health", International Federation of Psychiatric Epidemiology (IFPE), Jun 2013, Leipzig (DE), Germany Communication dans un congrès hal-04539659v1
Effets antagonistes de l’éducation et du revenu sur le risque d’accident vasculaire cérébral ischémique au sein d’une cohorte de personnes âgées Olivier Grimaud,Emmanuelle Leray,A. Alperovitch,C. Dufouil,P. Chauvin Congrès International ADELF-SFSP "Santé publique et prévention", ADELF & SFSP, Oct 2013, Bordeaux, France. pp.S112 / 16, ⟨10.1016/j.respe.2013.03.019⟩ Communication dans un congrès hal-04021795v1
Parental Use of Corporal Punishment in Europe: Intersection between Public Health and Policy. N. Durivage,Emmanuelle Leray,Christophe Fermanian,V. Kovess 20ème Congrès Mondial de la IACAPAP "Brain, Mind and Development", Association internationale de psychiatrie de l'enfant et de l'adolescent et des professions alliées (IACAPAP), Jul 2012, Paris, France Communication dans un congrès hal-04540211v1
Survimus, une étude multicentrique de la mortalité dans la sclérose en plaques, France Emmanuelle Leray,G. Edan Ve Congrès International d'Épidémiologie "Épidémiologie et santé mondialisée", ADELF, Sep 2012, Bruxelles, Belgique. pp.S59-S60 / C1-4, ⟨10.1016/j.respe.2012.06.056⟩ Communication dans un congrès hal-04021788v1
Comparison of Clinical and Biological Features of Invasive Aspergillosis in Neutropenic and Non-Neutropenic Patients A. Cornillet,Christophe Camus,S. Nimubona,Virginie Gandemer,Pierre Tattevinet al. 16th Congress of the International Society for Human and Animal Mycology, 2006, Paris, France Communication dans un congrès hal-00700372v1

Article dans une revue (123)

Healthcare trajectories following cancer surgery in older adults: insights from the French health data system Nicolas Bertrand,Héloïse Fauchon,Charline Jean,Estelle Neveu,Thomas Gilbertet al. BMC Geriatrics, 2026, Online ahead of print. ⟨10.1186/s12877-026-07273-5⟩ Article dans une revue hal-05548827v1
Mass medical evacuations to decrease the intensive care burden: results from the TRANSCOV cohort study. Olivier Grimaud,Emmanuelle Leray,Sahar Bayat,Christophe Fermanian,Sylvie Martinet al. Chest, 2026, 169 (2), pp.390-400. ⟨10.1016/j.chest.2025.08.023⟩ Article dans une revue hal-05274056v1
Analyzing recurrent events in multiple sclerosis: a review of statistical models with application to the MSOAC database David Herman,Julien Tanniou,Emmanuelle Leray,Chloe Pierret,Quentin Pilard Journal of Neurology, 2025, 272 (5), pp.371. ⟨10.1007/s00415-025-13100-5⟩ Article dans une revue hal-05069098v1
Influence of geographical accessibility to specialist and primary care givers on excess mortality of multiple sclerosis patients in France Sarah Wilson,Emmanuelle Leray,Floriane Calocer,Fabien Rollot,Mathieu Fauvernieret al. BMC Neurology, 2025, 25 (1), pp.441. ⟨10.1186/s12883-025-04459-z⟩ Article dans une revue hal-05339351v1
Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple Sclerosis Marie Mainguy,Romain Casey,Sandra Vukusic,Christine Lebrun-Frenay,Eric Bergeret al. Neurology Neuroimmunology & Neuroinflammation, 2025, 12 (2), pp.e200371. ⟨10.1212/NXI.0000000000200371⟩ Article dans une revue hal-04947771v1
Real-world persistence with sacubitril/valsartan in patients with heart failure in France: A claims database study Olivier Hanon,Ariel Cohen,Patrick Jourdain,Emmanuelle Leray,Gérard de Pouvourvilleet al. Archives of cardiovascular diseases, 2025, ⟨10.1016/j.acvd.2025.11.010⟩ Article dans une revue hal-05444661v1
Breast Cancer Screening in Women With Multiple Sclerosis: A Mixed‐Methods Study Chloe Pierret,Lou Philippe,Emmanuelle Leray European Journal of Neurology, 2025, 32 (5), ⟨10.1111/ene.70183⟩ Article dans une revue hal-05081677v1
Prognostic factors of disability progression in multiple sclerosis in real life: the OFSEP-high definition (OFSEP-HD) prospective cohort in France Guillemin Francis,Romain Casey,Epstein Jonathan,Foucher Yohann,David Laplaudet al. BMJ Open, 2025, 15 (4), pp.e094688. ⟨10.1136/bmjopen-2024-094688⟩ Article dans une revue hal-05033118v1
Environmental risk factors for multiple sclerosis: a comprehensive systematic review and meta-analysis Bruno Kusznir Vitturi,Maria Cellerino,Daniele Boccia,Emmanuelle Leray,Jorge Correaleet al. Journal of Neurology, 2025, 272 (8), pp.513. ⟨10.1007/s00415-025-13248-0⟩ Article dans une revue (article de synthèse) hal-05199735v1
Author Response: Cancer Risk Among Patients With Multiple Sclerosis: A 10-Year Nationwide Retrospective Cohort Study Chloe Pierret,Emmanuelle Leray Neurology, 2025, 105 (9), ⟨10.1212/WNL.0000000000210260⟩ Article dans une revue hal-05329313v1
Data linkage between the French multiple sclerosis cohort (OFSEP) and the French national health insurance database (SNDS) E. Leray,Erwan Drézen,Romain Casey,Sandra Vukusic Revue Neurologique, 2025, 181 (7), pp.624-631. ⟨10.1016/j.neurol.2025.05.002⟩ Article dans une revue hal-05110767v1
Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis Antoine Gavoille,Emmanuelle Leray,Romain Marignier,Fabien Rollot,Romain Caseyet al. Neurology, 2025, 105 (4), pp.e213907. ⟨10.1212/WNL.0000000000213907⟩ Article dans une revue hal-05214153v1
Childhood and Adolescent Environmental Risk Factors for Multiple Sclerosis: A Systematic Review With Meta‐Analysis Bruno Kusznir Vitturi,Maria Cellerino,Daniele Boccia,Emmanuelle Leray,Jorge Correaleet al. European Journal of Neurology, 2025, 32 (11), pp.e70398. ⟨10.1111/ene.70398⟩ Article dans une revue (compte-rendu de lecture) hal-05353780v1
Association between education level and access to disease-modifying treatment in patients with multiple sclerosis in France Mathilde Lefort,Olivier Dejardin,Eric Berger,Jean-Philippe Camdessanché,Jonathan Cironet al. Multiple Sclerosis Journal, 2025, 31 (1), pp.69-80. ⟨10.1177/13524585241289276⟩ Article dans une revue hal-04826502v1
Pregnancy and birth outcomes in women with multiple sclerosis: Comparison of the RESPONSE study to the general French population Elisabeth Maillart,Fabien Rollot,Emmanuelle Leray,Lakhdar Benyahya,Bertrand Bourreet al. Multiple Sclerosis Journal, 2025, 31 (3), pp.324 - 337. ⟨10.1177/13524585251316474⟩ Article dans une revue hal-05000197v1
Analysis of healthcare utilization before the diagnosis of radiologically isolated syndrome Christine Lebrun-Frénay,Sandrine Kerbrat,Darin Okuda,Cassandre Landes-Chateau,Orhun H Kantarciet al. Multiple Sclerosis Journal, 2025, 31 (2), pp.184-196. ⟨10.1177/13524585241291471⟩ Article dans une revue hal-04883813v1
Association between education level and disability progression in patients with multiple sclerosis in France Mathilde Lefort,Olivier Dejardin,Eric Berger,Jean-Philippe Camdessanché,Jonathan Cironet al. Multiple Sclerosis Journal, 2025, 31 (1), pp.59-68. ⟨10.1177/13524585241289274⟩ Article dans une revue hal-04814408v1
Prevalence of multiple sclerosis in France in 2021: Data from the French health insurance database C. Pierret,Marie Mainguy,Emmanuelle Leray Revue Neurologique, 2024, 180 (5), pp.429-437. ⟨10.1016/j.neurol.2023.12.007⟩ Article dans une revue hal-04487926v1
The Response Study: A French registry on pregnancy in women with MS and related disorders and their children up to 6 years—Protocol, recruitment status, and baseline characteristics Sandra Vukusic,Bertrand Bourre,Romain Casey,Kumaran Deiva,Anne-Marie Guennocet al. Multiple Sclerosis Journal, 2024, Multiple Sclerosis Journal, 30 (2), pp.216-226. ⟨10.1177/13524585231223390⟩ Article dans une revue hal-04432657v1
Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society Nicolas Collongues,Françoise Durand-Dubief,Christine Lebrun-Frénay,Bertrand Audoin,Xavier Ayrignacet al. Multiple Sclerosis Journal, 2024, Multiple Sclerosis Journal, 30 (7), pp.899-924. ⟨10.1177/13524585231223880⟩ Article dans une revue hal-04479762v1
Risk of Relapse After COVID-19 Vaccination Among Patients With Multiple Sclerosis in France Xavier Moisset,Emmanuelle Leray,Chouki Chenaf,Frederic Taithe,Sandra Vukusicet al. Neurology, 2024, 103 (5), pp.e209662. ⟨10.1212/wnl.0000000000209662⟩ Article dans une revue hal-04698925v1
Impact of multiple sclerosis on employment and income: Insights from a random sample representative of private sector employees in France using longitudinal administrative data Emmanuelle Leray,C. Regaert,E. Duguet,S. Guillaume,S. Pichettiet al. Revue Neurologique, 2024, 180 (8), pp.754-765. ⟨10.1016/j.neurol.2024.02.389⟩ Article dans une revue hal-04543869v1
Real-life study to assess effectiveness and safety of eculizumab in patients with neuromyelitis optica spectrum disorders in France: protocol for ECUP4, an observational study Romain Marignier,David Laplaud,Helene Zephir,Caroline Papeix,Emmanuelle Lerayet al. Frontiers in Neurology, 2024, 14, pp.1303874. ⟨10.3389/fneur.2023.1303874⟩ Article dans une revue hal-04432746v1
Conséquences financières de la mise en invalidité des personnes atteintes de sclérose en plaques et points de vue des malades. M. Espagnacq,S. Guillaume,Emmanuelle Leray Questions d'économie de la santé, 2024, 289, pp.1-8 Article dans une revue hal-04618296v1
Recommandations de la Société francophone de la sclérose en plaques « Vaccinations et sclérose en plaques » : mise à jour 2024 C. Lebrun-Frenay,C. Carra-Dallière,C. Louapre,C. Papeix,V. Pourcheret al. Pratique Neurologique - FMC, 2024, 15 (2), pp.105-113. ⟨10.1016/j.praneu.2024.04.001⟩ Article dans une revue hal-04578333v1
Cancer Risk Among Patients With Multiple Sclerosis Chloe Pierret,Aurelien Mulliez,Christine Le Bihan-Benjamin,Xavier Moisset,Philippe-Jean Bousquetet al. Neurology, 2024, 103 (9), pp.e209885. ⟨10.1212/WNL.0000000000209885⟩ Article dans une revue hal-04735377v1
Improving the decision to switch from first to second-line therapy in multiple sclerosis: a dynamic scoring system C. Sabathe,Romain Casey,S. Vukusic,Emmanuelle Leray,G. Matheyet al. Multiple Sclerosis Journal, 2023, 29 (2), pp.236-247. ⟨10.1177/13524585221139156⟩ Article dans une revue hal-04221685v1
The radiologically isolated syndrome: revised diagnostic criteria Christine Lebrun-Frénay,Darin Okuda,Aksel Siva,Cassandre Landes-Chateau,Christina Azevedoet al. Brain - A Journal of Neurology , 2023, 146 (8), pp.3431-3443. ⟨10.1093/brain/awad073⟩ Article dans une revue hal-04020134v1
Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society Sandra Vukusic,Clarisse Carra-Dalliere,Jonathan Ciron,Elisabeth Maillart,Laure Michelet al. Multiple Sclerosis Journal, 2023, 29 (1), pp.11-36. ⟨10.1177/13524585221129472⟩ Article dans une revue hal-03882738v1
Difficultés de maintien en emploi à la suite d'une sclérose en plaques : perte de salaire et rôle des revenus de substitution dans les ressources Maude Espagnacq,Emmanuelle Leray,Camille Regaert,Alice Guilleux,Sylvain Pichettiet al. Questions d'économie de la santé, 2023, 274, pp.1-8 Article dans une revue hal-04039661v1
Benefits of homeopathic complementary treatment in patients with breast cancer: A retrospective cohort study based on the French nationwide healthcare database J Medioni,D Scimeca,y Lopez Marquez,Emmanuelle Leray,M Dalichamptet al. Clinical Breast Cancer, 2023, 23 (1), pp.60-70. ⟨10.1016/j.clbc.2022.10.001⟩ Article dans une revue hal-03820830v1
Sclerosi multipla: epidemiologia Emmanuelle Leray EMC - Neurologia, 2023, 23 (4), pp.1-15. ⟨10.1016/S1634-7072(23)48431-0⟩ Article dans une revue hal-04316052v1
Comparison of Two Methods for Estimating MS-Related Mortality: The Excess Mortality vs. the Cause-Specific Frameworks Fabien Rollot,Zoe Uhry,Emmanuelle Dantony,Sandra Vukusic,Marc Debouverieet al. Neurology, 2023, 101 (24), pp.e2483-e2496. ⟨10.1212/WNL.0000000000207925⟩ Article dans une revue hal-04250392v1
Pregnancy-related healthcare utilization among women with multiple sclerosis Marie Mainguy,Emmanuelle Le Page,Laure Michel,Emmanuelle Leray Frontiers in Neurology, 2023, 14, ⟨10.3389/fneur.2023.1129117⟩ Article dans une revue hal-04021750v1
Low socioeconomic status was associated with a higher mortality risk in multiple sclerosis Floriane Calocer,Huah Shin Ng,Feng Zhu,Yinshan Zhao,Olivier Dejardinet al. Multiple Sclerosis Journal, 2023, 29 (3), pp.466-470. ⟨10.1177/13524585221129963⟩ Article dans une revue hal-03882628v1
Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study Sarah Wilson,Floriane Calocer,Fabien Rollot,Mathieu Fauvernier,Laurent Remontetet al. The Lancet Regional Health - Europe, 2023, 24, pp.100542. ⟨10.1016/j.lanepe.2022.100542⟩ Article dans une revue hal-03875120v1
Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society Sandra Vukusic,Romain Marignier,Jonathan Ciron,Bertrand Bourre,Mikael Cohenet al. Multiple Sclerosis Journal, 2023, 29 (1), pp.37-51. ⟨10.1177/13524585221130934⟩ Article dans une revue hal-04954569v1
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis Mathilde Lefort,S. Sharmin,J. Andersen,S. Vukusic,R. Caseyet al. BMC Medical Research Methodology, 2022, 22 (1), pp.155. ⟨10.1186/s12874-022-01623-8⟩ Article dans une revue hal-03690493v1
Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis Izanne Roos,Charles Malpas,Emmanuelle Leray,Romain Casey,Dana Horakovaet al. Neurology, 2022, 99 (17), pp.e1926-e1944. ⟨10.1212/WNL.0000000000201029⟩ Article dans une revue hal-03776286v1
Prescribing Trends for Valproate Among Pregnant Women: A Cross-sectional Study in 2013 and 2016 Using the French Health Insurance Database Adeline Degremont,Sandrine Kerbrat,Frédéric Balusson,Annie Pierre Jonville-Bera,Virginie Ringaet al. Neurology, 2022, 98 (21), pp.e2163-e2173. ⟨10.1212/WNL.0000000000200260⟩ Article dans une revue hal-03637138v1
Disability Progression in Multiple Sclerosis Patients using Early First-line Treatments Mathilde Lefort,Sandra Vukusic,Romain Casey,Gilles Edan,Emmanuelle Leray European Journal of Neurology, 2022, 29 (9), pp.2761-2771. ⟨10.1111/ene.15422⟩ Article dans une revue hal-03690316v1
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal Fabien Rollot,Justine Couturier,Romain Casey,Sandrine Wiertlewski,Marc Debouverieet al. Neurotherapeutics, 2022, 19 (2), pp.476-490. ⟨10.1007/s13311-022-01202-1⟩ Article dans une revue hal-03594074v1
Care consumption of people with multiple sclerosis: A multichannel sequence analysis in a population-based setting in British Columbia, Canada Jonathan Roux,Elaine Kingwell,Feng Zhu,Helen Tremlett,Emmanuelle Leray Multiple Sclerosis Journal, 2022, 28 (2), pp.309-322. ⟨10.1177/13524585211016726⟩ Article dans une revue hal-03246670v1
Trends in disease-modifying therapy use in patients with multiple sclerosis using a 10-year population-based cohort study in France Soline Leblanc,Mathilde Lefort,Emmanuelle Le Page,Laure Michel,Emmanuelle Leray Expert Review of Neurotherapeutics, 2022, 22 (5), pp.411-418. ⟨10.1080/14737175.2022.2061950⟩ Article dans une revue hal-03629848v1
Assessing the Risk of Relapse Requiring Corticosteroids After In Vitro Fertilization in Women With Multiple Sclerosis Marie Mainguy,Hélène Tillaut,Adeline Degremont,Emmanuelle Le Page,Christelle Mainguyet al. Neurology, 2022, 99 (17), pp.10.1212/WNL.0000000000201027. ⟨10.1212/WNL.0000000000201027⟩ Article dans une revue hal-03751891v1
Ten-year follow-up after mitoxantrone induction for early highly active relapsing-remitting multiple sclerosis: An observational study of 100 consecutive patients Mathilde Lefort,G. Le Corre,E. Le Page,C. Rizzato,D. Le Portet al. Revue Neurologique, 2022, 178 (6), pp.569-579. ⟨10.1016/j.neurol.2021.11.014⟩ Article dans une revue hal-03588900v1
Pregnancy in women with multiple sclerosis in France from 2010 to 2015: Incidence, outcomes, and exposure to disease-modifying therapies Hélène Tillaut,Adeline Degrémont,Sandrine Kerbrat,Jonathan Roux,Emmanuelle Le Pageet al. Multiple Sclerosis Journal, 2022, 28 (5), pp.778-789. ⟨10.1177/13524585211035376⟩ Article dans une revue hal-03819581v1
COPP-MS: COrticosteroids during the Post-Partum in relapsing Multiple Sclerosis patients Soizic Leguy,Mathilde Lefort,Lucile Lescot,Audrey Michaud,Sandra Vukusicet al. Journal of Neurology, 2022, 269 (269), pp.5571-5581. ⟨10.1007/s00415-022-11215-7⟩ Article dans une revue hal-03704177v1
Disease reactivation after fingolimod cessation in Multiple Sclerosis patients with pregnancy desire: A retrospective study Alix Callens,Soline Leblanc,Emmanuelle Le Page,Gilles Edan,Aurore Jourdainet al. Multiple Sclerosis and Related Disorders, 2022, 66, pp.104066. ⟨10.1016/j.msard.2022.104066⟩ Article dans une revue hal-03753568v1
Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study Caroline Papeix,Giovanni Castelnovo,Emmanuelle Leray,Marc Coustans,Pierre Levyet al. Neurology and Therapy, 2022, ⟨10.1007/s40120-022-00334-y⟩ Article dans une revue hal-03608016v1
Disease modifying therapies and disease activity during pregnancy and postpartum in a contemporary cohort of relapsing Multiple Sclerosis patients Lucile Lescot,Mathilde Lefort,Soizic Leguy,Emmanuelle Le Page,Sandra Vukusicet al. Multiple Sclerosis and Related Disorders, 2022, 68, pp.104122. ⟨10.1016/j.msard.2022.104122⟩ Article dans une revue hal-03776859v1
Disease-modifying therapy usage in patients with multiple sclerosis in France: A 6-year population-based study Soline Leblanc,Jonathan Roux,Hélène Tillaut,Emmanuelle Le Page,Emmanuelle Leray Revue Neurologique, 2021, 177 (10), pp.1250-1261. ⟨10.1016/j.neurol.2021.04.006⟩ Article dans une revue hal-03312766v1
Assessing environmental epidemiology questions in practice with a causal inference pipeline: An investigation of the air pollution-multiple sclerosis relapses relationship Alice J. Sommer,Emmanuelle Leray,Young Lee,Marie-Abele C. Bind Statistics in Medicine, 2021, 40 (6), pp.1321-1335. ⟨10.1002/sim.8843⟩ Article dans une revue hal-03101469v1
Effects of High and Low Efficacy Therapy in Secondary Progressive Multiple Sclerosis Izanne Roos,Emmanuelle Leray,Romain Casey,Dana Horakova,Eva Havrdovaet al. Neurology, 2021, 97 (9), pp.e869-e880. ⟨10.1212/WNL.0000000000012354⟩ Article dans une revue hal-03282036v1
Determinants of Therapeutic Lag in Multiple Sclerosis Izanne Roos,Emmanuelle Leray,Federico Frascoli,Romain Casey,J William L Brownet al. Multiple Sclerosis Journal, 2021, 27 (12), pp.1838-1851. ⟨10.1177/1352458520981300⟩ Article dans une revue hal-03223056v1
TRANSCOV cohort protocol: an epidemiological study assessing the impact of critically ill COVID-19 patients long distance transfers between intensive care units Olivier Grimaud,Sahar Bayat,Anne Renault,Eric Maury,Julien Pottecheret al. BMJ Open, 2021, 11 (10), pp.e054774. ⟨10.1136/bmjopen-2021-054774⟩ Article dans une revue hal-03405771v1
Effects of Age and Disease Duration on Excess Mortality in Patients With Multiple Sclerosis From a French Nationwide Cohort Fabien Rollot,Mathieu Fauvernier,Zoe Uhry,Sandra Vukusic,Nadine Bossardet al. Neurology, 2021, 97 (4), pp.e403-e413. ⟨10.1212/WNL.0000000000012224⟩ Article dans une revue hal-03246632v1
Cumulative effects of therapies on disability in relapsing multiple sclerosis Fabien Rollot,Romain Casey,Emmanuelle Leray,Marc Debouverie,Gilles Edanet al. Multiple Sclerosis Journal, 2021, 27 (11), pp.1760-1770. ⟨10.1177/1352458520980366⟩ Article dans une revue hal-03128421v1
Emulation d’essai clinique randomisé chez des patients atteints d’une sclérose en plaques pour estimer le bénéfice d’un changement de traitement précoce vers un traitement de seconde ligne : approche par scores de propensions dépendant du temps Camille Sabathé,Romain Casey,Sandra Vukusic,Emmanuelle Leray,David-Axel Laplaudet al. Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique, 2021, 69, pp.S85. ⟨10.1016/j.respe.2021.05.007⟩ Article dans une revue hal-03820873v1
The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies Johanna Andersen,Sifat Sharmin,Mathilde Lefort,Nils Koch-Henriksen,Finn Sellebjerget al. Multiple Sclerosis and Related Disorders, 2021, 53, pp.103012. ⟨10.1016/j.msard.2021.103012⟩ Article dans une revue hal-03268539v1
Impact of ICU transfers on the mortality rate of patients with COVID-19: insights from comprehensive national database in France Marc-Antoine Sanchez,Albert Vuagnat,Olivier Grimaud,Emmanuelle Leray,Jean-Marc Philippeet al. Annals of Intensive Care, 2021, 11 (1), ⟨10.1186/s13613-021-00933-2⟩ Article dans une revue hal-03411986v1
Benefits of homeopathic complementary treatment in breast cancer patients. A retrospective cohort. Mohammed Bennani,Jacques Medioni,Yecenia Lopez Marquez,Daniel Scimeca,Emmanuelle Lerayet al. European Journal of Integrative Medicine, 2021, 48, pp.101915. ⟨10.1016/j.eujim.2021.101915⟩ Article dans une revue hal-03820857v1
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts Sifat Sharmin,Mathilde Lefort,Johanna Balslev Andersen,Emmanuelle Leray,Dana Horakovaet al. CNS Drugs, 2021, 35 (11), pp.1217-1232. ⟨10.1007/s40263-021-00860-7⟩ Article dans une revue hal-03367246v1
Teriflunomide-exposed pregnancies in a French cohort of patients with multiple sclerosis Astrid Barataud-Reilhac,Sandrine Kerbrat,Jonathan Roux,Alice Guilleux,Elisabeth Polardet al. Neurology: Clinical Practice, 2020, 10 (4), pp.287-297. ⟨10.1212/CPJ.0000000000000717⟩ Article dans une revue hal-02955236v1
Decreasing impact of late relapses on disability worsening in secondary progressive multiple sclerosis Kevin Ahrweiller,Chloé Rousseau,Emmanuelle Le Page,Emma Bajeux,Emmanuelle Lerayet al. Multiple Sclerosis Journal, 2020, 26 (8), pp.924-935. ⟨10.1177/1352458519848090⟩ Article dans une revue hal-02150346v1
Long‐term effect of first‐line injectable multiple sclerosis treatments: input of a time‐dependent propensity score Mathilde Lefort,Yohann Foucher,Rémi Lenain,Sandra Vukusic,Gilles Edanet al. Pharmacoepidemiology and Drug Safety, 2020, 29 (12), pp.1680-1688. ⟨10.1002/pds.5154⟩ Article dans une revue hal-02979802v1
High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practice Laura Couloume,Laetitia Barbin,Emmanuelle Leray,Sandrine Wiertlewski,Emmanuelle Le Pageet al. Multiple Sclerosis Journal, 2020, 26 (14), pp.1898-1906. ⟨10.1177/1352458519894713⟩ Article dans une revue hal-02436685v1
Delay from treatment start to full effect of immunotherapies for multiple sclerosis Izanne Roos,Emmanuelle Leray,Federico Frascoli,Romain Casey,J William L Brownet al. Brain - A Journal of Neurology , 2020, 143 (9), pp.2742-2756. ⟨10.1093/brain/awaa231⟩ Article dans une revue hal-02955197v1
Prevalence of mental disorders is higher in patients with multiple sclerosis than in the general population or in patients with rheumatoid arthritis in France Alice Guilleux,Jonathan Roux,David Travers,Emmanuelle Leray Multiple Sclerosis Journal - Experimental, Translational and Clinical, 2020, 6 (3), pp.2055217320941540. ⟨10.1177/2055217320941540⟩ Article dans une revue hal-02960099v1
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition C Walton,Rachel King,Lindsay Rechtman,Wendy Kaye,Emmanuelle Lerayet al. Multiple Sclerosis Journal, 2020, 26 (14), pp.1816-1821. ⟨10.1177/1352458520970841⟩ Article dans une revue hal-03038709v1
High and low efficacy therapy in secondary progressive multiple sclerosis after accounting for therapeutic lag I. Roos,Emmanuelle Leray,Romain Casey,D. Horakova,E. Kubala Havrdovaet al. Multiple Sclerosis Journal, 2020, 26 (3_SUPPL), pp.534-535 Article dans une revue hal-03127244v1
Predictive medicine in multiple sclerosis: A systematic review Julie Havas,Emmanuelle Leray,Fabien Rollot,Romain Casey,Laure Michelet al. Multiple Sclerosis and Related Disorders, 2020, 40, pp.101928. ⟨10.1016/j.msard.2020.101928⟩ Article dans une revue hal-02470973v1
Urinary tract infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society C. Donzé,C. Papeix,C. Lebrun-Frenay,N. Collongues,M. de Sezeet al. Revue Neurologique, 2020, 176 (10), pp.804-822. ⟨10.1016/j.neurol.2020.02.011⟩ Article dans une revue hal-03339824v1
Prescription patterns of first- and second-generation antipsychotic drugs in the French population Viviane Kovess-Masféty,Frédéric Balusson,Emmanuelle Leray,Mathilde Husky,Lucie-Marie Scailteux Fundamental & Clinical Pharmacology, 2020, 34 (5), pp.603-611. ⟨10.1111/fcp.12553⟩ Article dans une revue hal-02534802v1
Use of state sequence analysis for care pathway analysis: The example of multiple sclerosis Jonathan Roux,Olivier Grimaud,Emmanuelle Leray Statistical Methods in Medical Research, 2019, 28 (6), pp.1651-1663. ⟨10.1177/0962280218772068⟩ Article dans une revue hal-01798652v1
Use of healthcare services by patients with multiple sclerosis in France over 2010-2015: a nationwide population-based study using health administrative data Jonathan Roux,Alice Guilleux,Mathilde Lefort,Emmanuelle Leray Multiple Sclerosis Journal - Experimental, Translational and Clinical, 2019, 5 (4), pp.2055217319896090. ⟨10.1177/2055217319896090⟩ Article dans une revue hal-02444012v1
Multiple sclerosis: effect of beta interferon treatment on survival Elaine Kingwell,Emmanuelle Leray,Feng Zhu,John Petkau,Gilles Edanet al. Brain - A Journal of Neurology , 2019, 142 (5), pp.1324-1333. ⟨10.1093/brain/awz055⟩ Article dans une revue hal-02088095v1
Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis David-Axel Laplaud,Romain Casey,Laetitia Barbin,Marc Debouverie,Jerome de Sèzeet al. Neurology, 2019, 93 (7), pp.e635-e646. ⟨10.1212/WNL.0000000000007938⟩ Article dans une revue inserm-02289153v1
Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society C. Lebrun,S. Vukusic,V. Abadie,C. Achour,F. Aderet al. Revue Neurologique, 2019, 175 (6), pp.341-357. ⟨10.1016/j.neurol.2019.04.001⟩ Article dans une revue hal-02546158v1
Multichannel sequence analysis: An innovative method to study patterns of care pathways. Application to multiple sclerosis based on French Health Insurance data Jonathan Roux,Olivier Grimaud,Emmanuelle Leray Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique, 2018, 66, pp.S430-S431. ⟨10.1016/j.respe.2018.05.534⟩ Article dans une revue hal-02921552v1
Ozone, NO2 and PM10 are associated with the occurrence of multiple sclerosis relapses. Evidence from seasonal multi-pollutant analyses Maxime Jeanjean,Marie-Abele Bind,Jonathan Roux,Jean-Claude Ongagna,Jérôme de Sèzeet al. Environmental Research, 2018, 163, pp.43-52. ⟨10.1016/j.envres.2018.01.040⟩ Article dans une revue hal-01740486v1
Incidence of pregnancy in women with multiple sclerosis treated with teriflunomide in France Emmanuelle Leray,A. Reilhac,S. Kerbrat,Jonathan Roux,E. Polard Multiple Sclerosis Journal, 2018, 24, pp.715-715 Article dans une revue hal-01939729v1
From medical prescription to patient compliance. A qualitative insight into the neurologist-patient relationship in multiple sclerosis V. Schlegel,Emmanuelle Leray International Journal of MS Care, 2018, 20 (6), pp.279-286. ⟨10.7224/1537-2073.2017-043⟩ Article dans une revue hal-02043814v1
Factors Associated with Parent–Child Discrepancies in Reports of Mental Health Disorders in Young Children Emma Bajeux,David Klemanski,Mathilde Husky,Emmanuelle Leray,Christine Chan Cheeet al. Child Psychiatry and Human Development, 2018, 49 (6), pp.1003-1010. ⟨10.1007/s10578-018-0815-7⟩ Article dans une revue hal-02436693v1
Air pollution by particulate matter PM10 may trigger multiple sclerosis relapses Jonathan Roux,Denis Bard,Estelle Le Pabic,Claire Ségala,Jacques Reiset al. Environmental Research, 2017, 156, pp.404-410. ⟨10.1016/j.envres.2017.03.049⟩ Article dans une revue hal-01519866v1
Identification des maladies neurodégénératives dans les bases de données médicoadministratives en France : revue systématique de la littérature A. Gallini,F. Moisan,G. Maura,L. Carcaillon-Bentata,Emmanuelle Lerayet al. Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique, 2017, 65 (4), pp.S183-S197. ⟨10.1016/j.respe.2017.01.115⟩ Article dans une revue hal-01519864v1
Mood disorders and multiple sclerosis: a study based upon the French national health insurance databases A. Guilleux,Jonathan Roux,Emmanuelle Leray Multiple Sclerosis Journal, 2017, 23, pp.755-755. ⟨10.26226/morressier.59a3e8b5d462b8028d8946e3⟩ Article dans une revue hal-01713271v1
An excessive risk of suicide may no longer be a reality for multiple sclerosis patients Shoshannah Kalson-Ray,Gilles Edan,Emmanuelle Leray Multiple Sclerosis Journal, 2017, 23 (6), pp.864-871. ⟨10.1177/1352458517699873⟩ Article dans une revue hal-01518889v1
Geographical Heterogeneity of Multiple Sclerosis Prevalence in France Diane Pivot,Marc Debouverie,Michel Grzebyk,David Brassat,Michel Clanetet al. PLoS ONE, 2016, 11 (12), pp.e0167556 (eCollection 2016). ⟨10.1371/journal.pone.0167556⟩ Article dans une revue inserm-01576154v1
Mental health of college students and their non-college-attending peers: results from a large French cross-sectional survey Viviane Kovess-Masféty,Emmanuelle Leray,Laure Denis,Mathilde Husky,Isabelle Pitrouet al. BMC Psychology, 2016, 4, pp.20. ⟨10.1186/s40359-016-0124-5⟩ Article dans une revue hal-02436738v1
Epidemiology of multiple sclerosis Emmanuelle Leray,Thibault Moreau,Agnès Fromont,Gilles Edan Revue Neurologique, 2016, 172 (1), pp.3-13. ⟨10.1016/j.neurol.2015.10.006⟩ Article dans une revue hal-01255824v1
Air pollution, a rising environmental risk factor for cognition, neuroinflammation and neurodegeneration: The clinical impact on children and beyond L. Calderón-Garcidueñas,Emmanuelle Leray,P. Heydarpour,R. Torres-Jardón,J Reis Revue Neurologique, 2016, 172 (1), pp.69-80. ⟨10.1016/j.neurol.2015.10.008⟩ Article dans une revue hal-01255833v1
Parental Use of Corporal Punishment in Europe: Intersection between Public Health and Policy Nathalie Durivage,Katherine Keyes,Emmanuelle Leray,Ondine Pez,Adina Bitfoiet al. PLoS ONE, 2015, 10 (2), pp.e0118059. ⟨10.1371/journal.pone.0118059⟩ Article dans une revue hal-02436918v1
Bereavement-related depression: Did the changes induced by DSM-V make a difference? Results from a large population-based survey of French residents Florence Clesse,Emmanuelle Leray,Florence Bodeau-Livinec,Mathilde Husky,Viviane Kovess-Masfety Journal of Affective Disorders, 2015, 182 (1), pp.82-90. ⟨10.1016/j.jad.2015.04.039⟩ Article dans une revue istex hal-02460653v1
Criteria improving multiple sclerosis diagnosis at the first MRI Nathalie Caucheteux,Adil Maarouf,Margaux Genevray,Emmanuelle Leray,Romain Deschampset al. Journal of Neurology, 2015, 262 (4), pp.979 - 987. ⟨10.1007/s00415-015-7668-9⟩ Article dans une revue hal-01378308v1
Psychotropic medication use in French children and adolescents Viviane Kovess,Sabine Choppin,Fei Gao,Mathilde Pivette,Mathilde Huskyet al. Journal of Child and Adolescent Psychopharmacology, 2015, 25 (2), pp.168--175. ⟨10.1089/cap.2014.0058⟩ Article dans une revue hal-01147097v1
Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patients. Anne Kerbrat,S Hamonic,Emmanuelle Leray,I Tron,Gilles Edanet al. European Journal of Neurology, 2015, 22 (3), pp.507-e35. ⟨10.1111/ene.12600⟩ Article dans une revue istex inserm-01103117v1
Alemtuzumab as rescue therapy in a cohort of 16 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational study. Emmanuelle Le Page,Véronique Deburghgraeve,Marie-Antoinette Lester,Isabelle Cardiet,Emmanuelle Lerayet al. Journal of Neurology, 2015, 262 (4), pp.1024-1034. ⟨10.1007/s00415-015-7653-3⟩ Article dans une revue hal-01132657v1
Register-based incidence of multiple sclerosis in Brittany (north-western France), 2000-2001. Jacqueline Yaouanq,Isabelle Tron,Anne Kerbrat,Emmanuelle Leray,S Hamonicet al. Acta Neurologica Scandinavica Supplementum, 2015, 131 (5), pp.321-328. ⟨10.1111/ane.12332⟩ Article dans une revue inserm-01103109v1
Preservation of Person-Specific Semantic Knowledge in Semantic Dementia: Does Direct Personal Experience Have a Specific Role? Julie A. Péron,Pascale Piolino,Sandrine Le Moal-Boursiquot,Isabelle Biseul,Emmanuelle Lerayet al. Frontiers in Human Neuroscience, 2015, 9, pp.625. ⟨10.3389/fnhum.2015.00625⟩ Article dans une revue hal-01239805v1
Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study Emmanuelle Leray,Sandra Vukusic,Marc Debouverie,Michel Clanet,Bruno Brochetet al. PLoS ONE, 2015, 10 (7), pp.1-12. ⟨10.1371/journal.pone.0132033⟩ Article dans une revue hal-01201656v1
Mortality following stroke during and after acute care according to neighbourhood deprivation: a disease registry study Olivier Grimaud,Emmanuelle Leray,Benoît Lalloué,Radouane Aghzaf,Jérôme Durieret al. Journal of Neurology, Neurosurgery and Psychiatry, 2014, 85 (12), pp.1313-1318. ⟨10.1136/jnnp-2013-307283⟩ Article dans une revue hal-02436963v1
Improving detection of ischemic lesions at 3Tesla with optimized diffusion-weighted magnetic resonance imaging Isabelle Ract,Jean-Christophe Ferré,Thomas Ronzière,Emmanuelle Leray,Béatrice Carsin-Nicolet al. Journal de Neuroradiologie / Journal of Neuroradiology, 2014, 41 (1), pp.45-51. ⟨10.1016/j.neurad.2013.04.003⟩ Article dans une revue istex inserm-00845255v1
Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study. Emmanuelle Leray,M. Coustans,Emmanuelle Le Page,J. Yaouanq,Joel Ogeret al. Multiple Sclerosis Journal, 2013, 19 (4), pp.458-65. ⟨10.1177/1352458512456613⟩ Article dans une revue hal-00878705v1
Pertinence et reproductibilité de l’interprétation de l’IRM dans les luxations et les lésions ligamentaires bicroisées du genou O. Barbier,B. Galaud,S. Descamps,P. Boisrenoult,Emmanuelle Lerayet al. Revue de Chirurgie Orthopédique et Traumatologique, 2013, 99 (3), pp.269-274. ⟨10.1016/j.rcot.2012.11.017⟩ Article dans une revue hal-02437002v1
Relevancy and reproducibility of magnetic resonance imaging (MRI) interpretation in multiple-ligament injuries and dislocations of the knee O. Barbier,B. Galaud,S. Descamps,P. Boisrenoult,Emmanuelle Lerayet al. Orthopaedics & Traumatology: Surgery & Research, 2013, 99 (3), pp.305-311. ⟨10.1016/j.otsr.2012.11.016⟩ Article dans une revue hal-02436991v1
Knowledge of TIA among general practitioners and emergency department physicians. A questionnaire survey in a French semi-rural area Serge A. Massengo,M. Cisse,C. Guiziou,Emmanuelle Leray,Yusuf A. Rajaballyet al. Clinical Neurology and Neurosurgery, 2013, 115 (8), pp.1457 - 1463. ⟨10.1016/j.clineuro.2013.01.026⟩ Article dans une revue istex hal-01576986v1
Natalizumab and drug holiday in clinical practice: an observational study in very active relapsing remitting multiple sclerosis patients Anne Kerbrat,Emmanuelle Le Page,Emmanuelle Leray,T. Anani,M. Coustanset al. Journal of the Neurological Sciences, 2011, 308 (1-2), pp.98--102. ⟨10.1016/j.jns.2011.05.043⟩ Article dans une revue istex hal-01147033v1
Major depressive disorder skews the recognition of emotional prosody. Julie Péron,Sarah El Tamer,Didier Grandjean,Emmanuelle Leray,David Traverset al. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2011, 35 (4), pp.987-96. ⟨10.1016/j.pnpbp.2011.01.019⟩ Article dans une revue istex hal-01133898v1
Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: A 5-year prospective study Emmanuelle Le Page,Emmanuelle Leray,Gilles Edan Multiple Sclerosis Journal, 2011, 17 (7), pp.867-875. ⟨10.1177/1352458511398371⟩ Article dans une revue hal-02437110v1
Prevalence, characteristics and comorbidities of anxiety disorders in France: results from the &quot;Mental Health in General Population&quot; survey (MHGP). Emmanuelle Leray,A Camara,D Drapier,F Riou,N Bougeantet al. European Psychiatry, 2011, 26 (6), pp.339-45. ⟨10.1016/j.eurpsy.2009.12.001⟩ Article dans une revue istex hal-01133893v1
Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial Gilles Edan,G. Comi,Emmanuelle Le Page,Emmanuelle Leray,M. Roccaet al. Journal of Neurology, Neurosurgery and Psychiatry, 2011, 82 (12), pp.1344-1350. ⟨10.1136/jnnp.2010.229724⟩ Article dans une revue istex hal-02437119v1
A new treatment era in multiple sclerosis: Clinical applications of new concepts Gilles Edan,Emmanuelle Leray Journal of the Neurological Sciences, 2011, 306 (1-2), pp.170-172. ⟨10.1016/j.jns.2010.09.018⟩ Article dans une revue istex hal-02437067v1
Apomorphine infusion in advanced Parkinson's patients with subthalamic stimulation contraindications. Sophie Drapier,Anne-Sophie Gillioz,Emmanuelle Leray,Julie Péron,Tiphaine Rouaudet al. Parkinsonism & Related Disorders, 2011, 18 (1), pp.40-4. ⟨10.1016/j.parkreldis.2011.08.010⟩ Article dans une revue istex hal-01133884v1
Decrease of prefrontal metabolism after subthalamic stimulation in obsessive-compulsive disorder: a positron emission tomography study. Florence Le Jeune,Marc Vérin,Karim N'Diaye,Dominique Drapier,Emmanuelle Lerayet al. Biological Psychiatry, 2010, 68 (11), pp.1016-22. ⟨10.1016/j.biopsych.2010.06.033⟩ Article dans une revue istex inserm-00667511v1
Subthalamic nucleus stimulation affects fear and sadness recognition in Parkinson's disease. Julie Péron,Isabelle Biseul,Emmanuelle Leray,Siobhan Vicente,Florence Le Jeuneet al. Neuropsychology, 2010, 24 (1), pp.1-8. ⟨10.1037/a0017433⟩ Article dans une revue hal-01133918v1
Influence of job seniority, hand hygiene education, and patient-to-nurse ratio on hand disinfection compliance. Sylvie Buffet-Bataillon,Emmanuelle Leray,Magali Poisson,Christian Michelet,Martine Bonnaure-Malletet al. Journal of Hospital Infection, 2010, 76 (1), pp.32-5. ⟨10.1016/j.jhin.2010.02.024⟩ Article dans une revue istex hal-00750826v1
Dislocation and bicruciate lesions of the knee: Epidemiology and acute stage assessment in a prospective series Sebastien Lustig,Emmanuelle Leray,P Boisrenoult,C Trojani,P Laffargueet al. Orthopaedics & Traumatology: Surgery & Research, 2009, 95, pp. 614-620. ⟨10.1016/j.otsr.2009.10.005⟩ Article dans une revue hal-00980675v1
Vascular lesions associated with bicruciate and knee dislocation ligamentous injury Philippe Boisrenoult,Sebastien Lustig,Paul Bonnevialle,Emmanuelle Leray,Gilbert Versieret al. Orthopaedics & Traumatology: Surgery & Research, 2009, 95 (8), pp. 621-626. ⟨10.1016/j.rcot.2009.10.001⟩ Article dans une revue hal-00981683v1
Are dopaminergic pathways involved in theory of mind? A study in Parkinson's disease Julie Péron,Siobhan Vicente,Emmanuelle Leray,Sophie Drapier,Dominique Drapieret al. Neuropsychologia, 2009, 47 (2), pp.406-414. ⟨10.1016/j.neuropsychologia.2008.09.008⟩ Article dans une revue istex hal-02956631v1
Long-term survival of patients with multiple sclerosis in West France E. Leray,Sp Morrissey,J. Yaouanq,M. Coustans,Emmanuelle Le Pageet al. Multiple Sclerosis Journal, 2007, 13 (7), pp.865-874. ⟨10.1177/1352458507077410⟩ Article dans une revue istex hal-02546138v1
Acute effects of biventricular pacing on right ventricular function assessed by tissue Doppler imaging. Erwan Donal,Noëlle Vignat,Christian de Place,Emmanuelle Leray,Christophe Crocqet al. EP-Europace, 2007, 9 (2), pp.108-12. ⟨10.1093/europace/eul175⟩ Article dans une revue inserm-00130056v1
Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. A. Cornillet,Christophe Camus,S. Nimubona,Virginie Gandemer,Pierre Tattevinet al. Clinical Infectious Diseases, 2006, 43 (5), pp.577-84. ⟨10.1086/505870⟩ Article dans une revue istex hal-00699980v1

Poster de conférence (39)

Validation clinique d’un algorithme d’identification de poussées de sclérose en plaques dans le système national de données de santé (SNDS) Bruno Brochet,Laure Carcaillon-Bentata,Abdelilah Abouelfath,Severine Lignot-Maleyran,Patrick Blinet al. Journées de Neurologie de Langue Française 2025, Apr 2025, Clermont-Ferrand, France. Elsevier, Revue Neurologique, 181 (Suppl.), pp.S35 / P254, 2025, ⟨10.1016/j.neurol.2025.01.261⟩ Poster de conférence hal-04999201v1
Données de vie réelle relatives à l’utilisation d’Éculizumab dans la prise en charge des maladies du spectre de la neuromyélite optique (NMOSD) en France : modalités d’utilisation, efficacité et tolérance (ECUP4) [P062] Jérôme de Sèze,Caroline Papeix,David-Axel Laplaud,Emmanuelle Leray,Mickaël Piotaixet al. Journées de Neurologie de Langue Française 2025, Apr 2025, Clermont-Ferrand, France. , Rev Neurol (Paris) - Revue Neurologique (ISSN : 0035-3787), 181 (Suppl.), pp.S134-S135, 2025, ⟨10.1016/j.neurol.2025.01.069⟩ Poster de conférence hal-04999262v1
Analysis of health care utilization before the diagnosis of radiologically isolated syndrome does not support the existence of a prodromal phase in multiple sclerosis Christine Lebrun-Frénay,Sandrine Kerbrat,Darin Okuda,Cassandre Landes-Château,Drezen Erwabet al. 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Sep 2024, Copenhagen, Denmark. SAGE PUBLICATIONS LTD, Multiple Sclerosis Journal, 30 (3), pp.125 - 680 / P034/124, 2024, Abstract Book. ⟨10.1177/13524585241269219⟩ Poster de conférence hal-05524156v1
Rehabilitation care for locomotor disorders in multiple sclerosis Marie Mainguy,Cécile Donze,Emmanuelle Leray 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Sep 2024, Copenhagen, Denmark. SAGE PUBLICATIONS LTD, Multiple Sclerosis Journal, 30 (3), pp.125 - 680 / P877/2174, 2024, ⟨10.1177/13524585241269219⟩ Poster de conférence hal-04882250v1
Is there therapeutic inertia in women with MS? Antoine Gavoille,Emmanuelle Leray,Fabien Rollot,Romain Casey,Guillaume Matheyet al. 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Sep 2024, Copenhagen, Denmark. SAGE PUBLICATIONS LTD, Multiple Sclerosis Journal, 30 (3), pp.125 - 680 / P034/124, 2024, ⟨10.1177/13524585241269219⟩ Poster de conférence hal-04888270v1
Multiple sclerosis-related healthcare and disease-modifying drug use before and after a cancer diagnosis Chloe Pierret,Sandra Vukusic,Christine Lebrun-Frénay,Géraldine Androdias,Huah Shin Nget al. 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Sep 2024, Copenhagen, Denmark. SAGE PUBLICATIONS LTD, Multiple Sclerosis Journal, 30 (3), pp.681 - 1137 / P1311/267, 2024, Abstract Book. ⟨10.1177/13524585241269221⟩ Poster de conférence hal-04882262v1
Assessing the risk of relapse after in vitro fertilization in women with multiple sclerosis Marie Mainguy,Romain Casey,Sandra Vukusic,Emmanuelle Leray,David‐axel Laplaud 9th Joint ECTRIMS-ACTRIMS meeting, Oct 2023, Milan, Italy. SAGE PUBLICATIONS LTD, Multiple Sclerosis Journal, 29 (3), pp.137-393 / P063/1244, 2023, Abstract Book. ⟨10.1177/13524585231196192⟩ Poster de conférence hal-04415216v1
Mortalité liée à la SEP et aux autres causes de décès chez les patients SEP [P29.32] Fabien Rollot,Zoé Uhry,Emmanuelle Dantony,Mathieu Fauvernier,Laurent Remontetet al. Journées de Neurologie de Langue Française (JNLF) 2023, Apr 2023, Lyon, France. Elsevier, Revue Neurologique, 179 (supplément), pp.S158, 2023, ⟨10.1016/j.neurol.2023.01.682⟩ Poster de conférence hal-04257509v1
Cancer risk among patients with MS : a 10-year nationwide cohort study using the French medico-administrative database (2012-2021) Chloe Pierret,Aurélien Mulliez,Christine Le Bihan-Benjamin,Xavier Moisset,Philippe-Jean Bousquetet al. 9th Joint ECTRIMS-ACTRIMS meeting, Oct 2023, Milan, Italy. SAGE PUBLICATIONS LTD, Multiple Sclerosis journal, 29 (3), pp.137-393 / P1223/251, 2023, Abstract Book. ⟨10.1177/13524585231196195⟩ Poster de conférence hal-04388002v1
Impact de la SEP sur les trajectoires professionnelles [P29.29] Emmanuelle Leray,Maude Espagnacq,Regaert Camille,Sylvain Pichetti,Guillaume Stéphanieet al. Journées de Neurologie de Langue Française (JNLF) 2023, Apr 2023, Lyon, France. Elsevier, Revue Neurologique, 179 (supplément), pp.S158, 2023, ⟨10.1016/j.neurol.2023.01.679⟩ Poster de conférence hal-04257519v1
Can we accurately assess disease activity using automated methods in large real-life MRI databases? Insights from the OFSEP HD database. Arthur Masson,Benoit Combès,Romain Casey,François Cotton,Alice Dufeyet al. 9th Joint ECTRIMS-ACTRIMS meeting, Oct 2023, Milan, Italy. Sage Publications Ltd, Multiple Sclerosis Journal, 29 (3S), pp.P269, 2023 Poster de conférence hal-04732264v1
Can we accurately assess disease activity using automated methods in large real-life MRI databases? Arthur Masson,Benoit Combès,Romain Casey,François Cotton,Alice Dufeyet al. MSMilan2023, Oct 2023, Milano (Italy), Italy. 2023 Poster de conférence hal-04250265v1
Influence of socio-economic status on excess mortality of multiple sclerosis Sharon A. Wilson,F. Calocer,F. Rollot,M. Fauvernier,L Remontetet al. ECTRIMS 2023 (39e Congrès annuel du Comité européen pour le traitement et la recherche sur la sclérose en plaques), Oct 2023, Milan, Italy. Sage Journals, Multiple Sclerosis Journal, 29 (3_SUPPL), pp.456-457, 2023 Poster de conférence hal-03925229v1
Pregnancy and birth outcomes in MS women : comparison of the RESPONSE cohort to the general French population Elisabeth Maillart,Bertrand Bourre,Romain Casey,Kumaran Deiva,Anne-Marie Guennocet al. 9th Joint ECTRIMS-ACTRIMS meeting, Oct 2023, Milan, Italy. SAGE PUBLICATIONS LTD, Multiple Sclerosis Journal, 29 (3), pp.137-393 / P462/188, 2023, Abstract Book. ⟨10.1177/13524585231196194⟩ Poster de conférence hal-04388000v1
Use of pregnancy-related healthcare in women with multiple sclerosis M. Mainguy,E. Le Page,Laure Michel,Emmanuelle Leray Meeting 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Oct 2022, Amsterdam, Netherlands. , Multiple Sclerosis Journal, 28 (3_SUPPL), pp.461-462 / P475, 2022, ⟨10.1177/13524585221123687⟩ Poster de conférence hal-03922624v1
Comparaison des anti-CD20 et du natalizumab chez des patients avec une SEP très active Fabien Rollot,Couturier Justine,Romain Casey,Emmanuelle Leray,Sandra Vukusicet al. Journées de Neurologie de Langue Française (JNLF) 2022, Apr 2022, Strasbourg, France. , Revue Neurologique, 178 (Suppl.), pp.S111, 2022, ⟨10.1016/j.neurol.2022.02.381⟩ Poster de conférence hal-03820845v1
Pregnancy in women with Neuromyelitis Optica Spectrum Disorders: Recommendations from the French Multiple Sclerosis Society (P13-4.006) Sandra Vukusic,Jonathan Ciron,Clarisse Carra-Dalliere,Elisabeth Maillart,Laure Michelet al. 74ème Congrès annuel de l'American Academy of Neurology (AAN 2022), Apr 2022, Seattle, United States. , Neurology, 98 (18(supplement)), pp.1741, 2022, ⟨10.1212/wnl.98.18_supplement.1741⟩ Poster de conférence hal-03922758v1
Disease reactivation after cessation of disease-modifying therapy in relapsing-remitting multiple sclerosis Izanne Roos,Charles Malpas,Emmanuelle Leray,Romain Casey,Dana Horakovaet al. 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2021), Oct 2021, Virtuel - Online, France. Sage, MULTIPLE SCLEROSIS JOURNAL, 27 (Suppl 2), pp.673-676, ePoster 878, 2021 Poster de conférence hal-04772073v1
Clinical course and therapeutic management of spms in france: a retrospective real world multicentric observational study (odyssep study) Emmanuelle Leray,A. Bastien,K. Rerat,A. Cognee-Chauvin,E. Raponiet al. MSVirtual2020 - 8th Joint ACTRIMS-ECTRIMS Meeting, Sep 2020, Virtuel, United States. , Multiple Sclerosis Journal, 26 (3_SUPPL), pp.524-525 / P0855, 2020, ⟨10.1177/1352458520974937⟩ Poster de conférence hal-03105858v1
Descriptif des caractéristiques des personnes ayant une sclérose en plaques en France et de leur recours aux soins à partir du Système National des Données de Santé en 2010-2015 Jonathan Roux,Alice Guilleux,Mathilde Lefort,Emmanuelle Leray 24èmes Journées de Neurologie de Langue Française, Apr 2019, Lille, France. , Revue Neurologique, 175 (N° S1), pp.S86-S87, 2019, ⟨10.1016/j.neurol.2019.01.241⟩ Poster de conférence istex hal-02921515v1
Prevalence of paediatric-onset multiple sclerosis in France, disease management and use of disease-modifying therapies in this specific population Emmanuelle Leray,M. Peron,Christophe Fermanian,E. Maillart,K. Deiva 35ème Congrès de l'ECTRIMS, Sep 2019, Stockhlom, Sweden. Sage Journals, Multiple Sclerosis Journal, 25 (2), pp.131-356 / P376, 2019, Abstract Book. ⟨10.1177/1352458519868078⟩ Poster de conférence hal-02363489v1
Baseline characteristics of the first patients included in the OFSEP high definition cohort and relationship between quality of life and patients' characteristics Romain Casey,I. El-Bahi,F. Rollot,Francis Guillemin,David-Axel Laplaudet al. 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Sep 2019, Stockhlom, Sweden. Sage Journals, Multiple Sclerosis Journal, 25 (2_suppl), pp.131 - 356 / P450, 2019, ⟨10.1177/1352458519868078⟩ Poster de conférence hal-02363488v1
Care-seeking of patients with multiple sclerosis over 2010-2015 in France - a nationwide study using health administrative data Jonathan Roux,A. Guilleux,Olivier Grimaud,Emmanuelle Leray 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Oct 2018, Berlin, Germany. Sage Journals, Multiple Sclerosis Journal, 24, pp.550-551 / P1000, 2018, ⟨10.1177/1352458518798591⟩ Poster de conférence hal-01935074v1
Assessing the cumulative effects of disease-modifying therapies on the current risk of irreversible disability in patients with relapsing-remitting multiple sclerosis F. Rollot,Romain Casey,Marc Debouverie,Gilles Edan,S. Wiertlewskiet al. ECTRIMS 2018, Oct 2018, Berlin, Germany. Sage Journals, Multiple Sclerosis Journal, 24 (Issue 2), pp.344-345 / P677, 2018, ⟨10.1177/1352458518798590⟩ Poster de conférence hal-01935071v1
Impact of new oral disease-modifying therapies on the prescription of injectable and off-label drugs in multiple sclerosis in France over 2011-2015 using national administrative databases Jonathan Roux,Alice Guilleux,Emmanuelle Leray 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), Aug 2018, Prague, Czech Republic. Wiley, Pharmacoepidemiology and Drug Safety, 27, pp.319-320 / 697, 2018, ⟨10.1002/pds.4629⟩ Poster de conférence hal-01879625v1
Care-seeking and disease modifying therapies use among multiple sclerosis patients with and without mental disorders - a population-based study A. Guilleux,Jonathan Roux,Emmanuelle Leray 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Oct 2018, Berlin, France. Sage Journals, Multiple Sclerosis Journal, 24, pp.377-378 / P733, 2018, ⟨10.1177/1352458518798590⟩ Poster de conférence hal-01935070v1
Quelle utilisation des traitements de fond chez des patients ayant une SEP rémittente en France sur la période 1990–2017 ? Éléments de réponse à partir des données de l’Ofsep Emmanuelle Leray,Fabien Rollot,Romain Casey,Jonathan Roux,Jérôme de Sezeet al. Journées de Neurologie de langue française 2018, Apr 2018, Bordeaux, France. , Revue Neurologique, 174, pp.S101, 2018, ⟨10.1016/j.neurol.2018.01.228⟩ Poster de conférence istex hal-02921615v1
The OFSEP high definition cohort to prognosticate the evolution of multiple sclerosis at clinical key steps of the disease Romain Casey,Francis Guillemin,David-Axel Laplaud,Emmanuelle Leray,J. Epsteinet al. 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Oct 2018, Berlin, Germany. Sage Journals, Multiple Sclerosis Journal, 24 (2), pp.738 - 980 / EP1359, 2018, ⟨10.1177/1352458518798592⟩ Poster de conférence hal-01939727v1
Long-term effect of interferon-beta use in real-world settings on disability progression a series of 2,451 relapsing-remitting multiple sclerosis patients, Rennes, France Mathilde Lefort,M. Goetz,Gilles Edan,Emmanuelle Leray MSPARIS2017, Oct 2017, Paris, France. Sage Journals, Multiple Sclerosis Journal, 23 (3_suppl), pp.633-634 / P1197, 2017, ⟨10.1177/1352458517731406⟩ Poster de conférence hal-01715984v1
Short-term exposure to ambient air pollution and occurrence of multiple sclerosis relapses M. Jeanjean,M. -A. Bind,Jonathan Roux,J. -C. Ongagna,J. de Sezeet al. MSPARIS2017, Oct 2017, Paris, France. Sage Journals, Multiple Sclerosis Journal, 23 (3), pp.209-210 / P490, 2017, ⟨10.1177/1352458517731404⟩ Poster de conférence hal-01715987v1
Adherence to oral versus injectable disease-modifying therapies for multiple sclerosis using French national health insurance databases Jonathan Roux,A. Guilleux,Emmanuelle Leray MSPARIS2017, Oct 2017, Paris, France. Sage Journals, Multiple Sclerosis Journal, 23 (3_suppl), pp.899-900 / EP1708, 2017, ⟨10.1177/1352458517731285⟩ Poster de conférence hal-01684631v1
Disease-modifying therapies use in primary progressive multiple sclerosis patients in France data from the OFSEP cohort over the 1996-2017 period Emmanuelle Leray,F. Rollot,Romain Casey,J. de Seze,D. A. Laplaudet al. MSPARIS2017, Oct 2017, Paris, France. Sage Journals, Multiple Sclerosis Journal, 23 (3_suppl), pp.659-660 / P1237, 2017, ⟨10.1177/1352458517731406⟩ Poster de conférence hal-01716028v1
Disease-modifying therapies use in relapsing-onset multiple sclerosis patients in real-life settings in France data from the OFSEP database over the period 1996-2017 Emmanuelle Leray,F. Rollot,Romain Casey,J. de Seze,D. A. Laplaudet al. MSPARIS2017, Oct 2017, Paris, France. Sage Journals, Multiple Sclerosis Journal, 23 (3 suppl), pp.709-709 / EP1335, 2017, ⟨10.1177/1352458517731285⟩ Poster de conférence hal-01716027v1
Care consumption of multiple sclerosis patients in France an analysis of health insurance administrative databases using multichannel sequence analysis from 2007 to 2013 Jonathan Roux,Olivier Grimaud,Emmanuelle Leray MSPARIS2017, Oct 2017, Paris, France. Sage Journals, Multiple Sclerosis Journal, 23 (3), pp.717 / EP1351, 2017, ⟨10.1177/1352458517731285⟩ Poster de conférence hal-01715986v1
Consommations de soins des patients atteints de sclérose en plaques en France de 2007 à 2013 à partir des bases de données médico-administratives J. Roux,Nolwenn Le Meur,Olivier Grimaud,Emmanuelle Leray Journées de Neurologie de langue française 2016, Apr 2016, Nantes, France. Elsevier, Revue Neurologique, 172 (Supplement 1), pp.A88 / W18, 2016, ⟨10.1016/j.neurol.2016.01.212⟩ Poster de conférence hal-01740325v1
Does air pollution influence risk of relapse in multiple sclerosis ? Emmanuelle Leray,E. Le Pabic,Christophe Fermanian,J. C. Ongagna,Denis Bardet al. 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Oct 2015, Barcelone, Spain. Sage Journals, Multiple Sclerosis Journal, 21 (11), pp.742--743 / EP1421, 2015, ⟨10.1177/135245851560263⟩ Poster de conférence hal-01259394v1
Long-term efficacy, safety, tolerability and quality of life with fingolimod treatment in patients with multiple sclerosis in real-world settings in France: VIRGILE study design M. Coustans,Marc Debouverie,G. Kobelt,Christine Lebrun-Frénay,Emmanuelle Lerayet al. 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Oct 2015, Barcelone, Spain. Sage Journals, Multiple Sclerosis Journal, 21 (11), pp.654-779 / EP1464, 2015, ⟨10.1177/135245851560263⟩ Poster de conférence hal-05517452v1
Inégalités sociales vis-à-vis de la létalité consécutive à un accident vasculaire cérébral, Dijon, France Olivier Grimaud,Emmanuelle Leray,B. Lalloué,J. Durier,M. Giroudet al. Congrès International ADELF-SFSP "Santé publique et prévention", Oct 2013, Bordeaux, France. Elsevier, Revue d'Épidémiologie et de Santé Publique, 61 (Supplement 4), pp.S315 / P10-9, 2013, ⟨10.1016/j.respe.2013.07.375⟩ Poster de conférence hal-04021813v1
Des différences d’état de santé mentale entre actifs, scolarisés et demandeurs d’emploi chez les 18–24ans, France Emmanuelle Leray,L. Denis,Viviane Kovess-Masfety Congrès International ADELF-SFSP "Santé publique et prévention", Oct 2013, Bordeaux, France. Elsevier, Revue d'Épidémiologie et de Santé Publique, 61 (Supplement 4), pp.S270-S271 / P1-20, 2013, ⟨10.1016/j.respe.2013.07.214⟩ Poster de conférence hal-04021827v1

Article de blog scientifique (1)

Octobre rose : et si on parlait aussi du dépistage chez les femmes atteintes d’une maladie chronique, comme la sclérose en plaques ? Emmanuelle Leray 2025, ⟨10.64628/AAK.5af5kndgp⟩ Article de blog scientifique hal-05349836v1

Ouvrages (2)

La princesse qui se prenait les pieds dans tous les tapis Gabrielle De Livron,Marguerite De Livron,Emmanuelle Leray,Cécile Hernandez Presses de l'EHESP, 32p., 2023, 978-2-8109-1092-2 Ouvrages hal-04020225v1
Glossaire d’épidémiologie. 50 notions pour comprendre la pandémie de Covid-19 Mélanie Bertin,Pascal Crepey,Olivier Grimaud,Nolwenn Le Meur,Emmanuelle Lerayet al. Presses de l’EHESP, 48p., 2021, 9782810909537. ⟨10.3917/ehesp.berti.2021.01⟩ Ouvrages hal-03312283v1